20 LATEST RESOURCES (77 INDEXED)
The Rates and Measurement of Adherence to Acamprosate in Randomised Controlled Clinical Trials: A Systematic Review · February 2022
Articles
PLOS ONE
Adherence to Prescribed Acamprosate in Alcohol Dependence and 1-Year Morbidities and Mortality: Utilizing a Data Linkage Methodology · May 2021
Articles
Journal of Clinical Medicine
A Comparative Study on the Safety and Efficacy of Naltrexone versus Baclofen versus Acamprosate in the Management of Alcohol Dependence · December 2020
Articles
Indian Journal of Psychiatry
Combination of Acamprosate and Baclofen (PXT864) as a Potential New Therapy for Amyotrophic Lateral Sclerosis · August 2020
Articles
Journal of Neuroscience Research
Impact of Acamprosate on Chronic Tinnitus: A Randomized-Controlled Trial · June 2020
Abstracts
Annals of Otology, Rhinology and Laryngology
Cost-Effectiveness Analysis of Genotype-Guided Treatment Allocation in Patients with Alcohol Use Disorders Using Naltrexone or Acamprosate, Using a Modeling Approach · November 2018
Articles
European Addiction Research
Risk of Hospitalisation and Death Related to Baclofen for Alcohol Use Disorders: Comparison with Nalmefene, Acamprosate, and Naltrexone in a Cohort Study of 165 334 Patients Between 2009 and 2015 in France · September 2018
Articles
Pharmacoepidemiology and Drug Safety
Prevalence and Safety of Acamprosate Use in Pregnant Alcohol-Dependent Women in New South Wales, Australia · August 2018
Abstracts
Addiction
Pharmacologically Controlled Drinking in the Treatment of Alcohol Dependence or Alcohol Use Disorders: A Systematic Review with Direct and Network Meta-Analyses on Nalmefene, Naltrexone, Acamprosate, Baclofen and Topiramate · September 2017
Articles (Manuscripts-Versions)
HAL>Addiction
Metabolomics Biomarkers to Predict Acamprosate Treatment Response in Alcohol-Dependent Subjects · May 2017
Articles
Scientific Reports
Anterior Cingulate Glutamate Is Reduced by Acamprosate Treatment in Patients with Alcohol Dependence · December 2016
Articles (Manuscripts-Versions)
PubMed Central>Journal of Clinical Psychopharmacology
The Diffusion of Acamprosate for the Treatment of Alcohol Use Disorder: Results from a National Longitudinal Study · December 2015
Articles (Manuscripts-Versions)
PubMed Central>Journal of Substance Abuse Treatment
Combination of Acamprosate and Baclofen as a Promising Therapeutic Approach for Parkinson’s Disease · November 2015
Articles
Scientific Reports
Elevated Baseline Serum Glutamate as a Pharmacometabolomic Biomarker for Acamprosate Treatment Outcome in Alcohol-Dependent Subjects · August 2015
Articles
Translational Psychiatry
An Analysis of Moderators in the COMBINE Study: Identifying Subgroups of Patients Who Benefit from Acamprosate · June 2015
Articles (Manuscripts-Versions)
PubMed Central>European Neuropsychopharmacology
The Efficacy of Acamprosate and Naltrexone in the Treatment of Alcohol Dependence, Europe versus the Rest of the World: A Meta-Analysis · February 2015
Abstracts
Addiction
Efficacy of Acamprosate for the Treatment of Alcohol Dependence Long After Recovery from Withdrawal Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study Conducted in Japan (Sunrise Study) · February 2015
Abstracts
Journal of Clinical Psychiatry
Six-Month Outcome in Bipolar Spectrum Alcoholics Treated with Acamprosate after Detoxification: A Retrospective Study · December 2014
Articles
International Journal of Environmental Research and Public Health
Genetic Markers Associated with Abstinence Length in Alcohol-Dependent Subjects Treated with Acamprosate · October 2014
Articles
Translational Psychiatry